Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Parallel Synthesis Technologies (PST) is a life science tools company that specializes in the development and manufacture of encoded microcarriers for high-throughput screening and combinatorial chemistry. The company's core technology, ParSyn beads, utilizes a proprietary optical encoding system that allows for the identification of individual beads within massive chemical or biological libraries. This technology is particularly valuable for 'split-and-pool' synthesis, enabling researchers to track the synthetic history of compounds and rapidly identify lead candidates in drug discovery. In addition to the encoded beads, PST provides the necessary decoding instrumentation and software to facilitate seamless integration into laboratory workflows. Their products are used by pharmaceutical companies, biotechnology firms, and academic institutions worldwide to accelerate the discovery of new therapeutics and materials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Parallel Synthesis Technologies.